Elsevier

Gene

Volume 502, Issue 2, 10 July 2012, Pages 159-162
Gene

Short Communication
Quantitative evaluation of common polymorphism (rs1801282) in the PPARγ2 gene and hypertension susceptibility

https://doi.org/10.1016/j.gene.2012.04.035Get rights and content

Abstract

The peroxisome proliferator-activated receptor-γ2 (PPARγ2) gene has been implicated in the etiology of hypertension. However, the results have been inconsistent. In this study, a meta-analysis was performed to assess the association of PPARγ2 rs1801282 polymorphism with hypertension risk. Published literature from PubMed, Embase databases, CNKI and Wanfang Data were retrieved. Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using fixed- or random-effects model. Eight studies (1865 cases and 1416 controls) for rs1801282 polymorphism were identified. The results suggested that rs1801282 polymorphism Ala allele might be protective for hypertension among East Asians (Ala/Ala + Pro/Ala vs. Pro/Pro: OR = 0.63, 95%CI 0.46–0.86) but not among Caucasians (Ala/Ala + Pro/Ala vs. Pro/Pro: OR = 0.72, 95%CI 0.38–1.38). The results indicated the significant association of PPARγ2 rs1801282 polymorphism with hypertension susceptibility among East Asians.

Highlights

► The PPARγ2 gene has been implicated in the etiology of hypertension. ► Eight studies (1865 cases and 1416 controls) for rs1801282 variant were identified. ► There was a significant association of PPARγ2 variant with hypertension risk.

Introduction

Hypertension is a serious public health issue worldwide, which affects 18% of Chinese adult population (Wu et al., 2008). Hypertension is a complex disease influenced by genes, environmental factors, and their interactions (Harrison et al., 2008). Twin and family studies have suggested that approximately of 20%–60% of blood pressure variation could be attributed to genetics (Kurtz and Spence, 1993). Up to now, many candidate genes have been reported to be implicated in the regulation of blood pressure and the susceptibility of hypertension. In addition, several genome wide association studies also identified many susceptibility loci which were associated with BP and hypertension (Levy et al., 2009, Newton-Cheh et al., 2009).

Peroxisome proliferator-activated receptor-γ (PPARγ), a member of the nuclear hormone receptor superfamily, is highly expressed in adipocytes and regulates the transcription of many adipocyte-specific genes (Tontonoz et al., 1995). Several polymorphisms in the PPARγ gene have been reported, and rs1801282 (Pro12Ala) is most frequently investigated. This polymorphism was first identified to have a key role in the development of obesity, insulin resistance and type 2 diabetes (Yen et al., 1997). Subsequently, it had been studied as a candidate for susceptibility to hypertension and the results have been conflicting (Dong, 2009, Gao et al., 2010, Gouni-Berthold et al., 2005, Lu et al., 2008, Pan et al., 2007, Rodríguez-Esparragón et al., 2003, Shen and Ha, 2004, Zhang et al., 2005a).

Meta-analysis is a useful method to overcome the disadvantages of individual studies, thereby increasing the statistical power and the precision of effect estimates. In this study, we performed a meta-analysis to assess the association of rs1801282 polymorphism in the PPARγ gene with hypertension susceptibility.

Section snippets

Literature and search strategy

We searched the literature databases including PubMed, Embase, China National Knowledge Infrastructure and Wanfang Data. The search strategy to identify all possible studies involved the use of the following key words: (“Peroxisome proliferator-activated receptor-γ2” or “PPARγ2”) and (“variant” or “polymorphism”) and (“hypertension”). All relevant studies were limited to ones published in English or Chinese language. The reference lists of retrieved articles were hand-searched. If more than one

Characteristics of the studies

The literature search identified a total of 28 potentially relevant papers. Of these, 17 were excluded because of obvious irrelevance by reading the titles and abstracts. In addition, one study (Zhang et al., 2005b) was excluded because it was one duplicated publication; one study was excluded because it defined hypertension as systolic/diastolic blood pressure  130/85 mm Hg (Kim et al., 2007), and one study (Horiki et al., 2004) was excluded because it did not provide sufficient data for

Discussion

To our knowledge, this is the first meta-analysis which comprehensively assessed the association between rs1801282 polymorphism in the PPARγ2 gene and hypertension risk. In this study, both English and Chinese databases were searched to avoid the language and selection biases. The results indicated that PPARγ2 rs1801282 polymorphism Ala allele was associated with reduced hypertension risk among East Asians. However, no significant association was found among Europeans. It is possible that the

Authors' roles

Chibo Liu designed research/study. Yujun Wang and Chibo Liu performed research/ study, collected data, analyzed data, wrote the paper, reviewed/edited the manuscript.

Conflict of interest

The authors have declared that no conflict of interest exists.

References (29)

  • M. Egger et al.

    Bias in meta-analysis detected by a simple, graphical test

    BMJ

    (1997)
  • L. Gao et al.

    Association of the PPARgamma2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia

    Genet. Mol. Res.

    (2010)
  • H.N. Gouda et al.

    The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis

    Am. J. Epidemiol.

    (2010)
  • I. Gouni-Berthold

    Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2

    J. Hypertens.

    (2005)
  • Cited by (0)

    View full text